of the American Journal of Rhinology and Allergy, in which they reviewed their experience with sinonasal polyposis in the elderly. The authors performed a very accurate investigation and concluded that there is a lower recurrence rate for chronic rhinosinusitis with nasal polyposis (CRSwNP) in the elderly in comparison with adult patients. As well underlined by the authors, many cytologic and immunologic studies show "physiologic hypoactivity" of sinus and nasal mucosa in the elderly. 2,3 Our experience with CRSwNP in the elderly confirms the data of Brescia et al., 1 who found a lower recurrence rate after functional endoscopic sinus surgery in comparison with an adult population. We also noticed that, as reported in yet other articles, 4 the geriatric population typically shows a greater postoperative satisfaction compared with the younger participants; the greater degree of recovery can be attributed to their worse and longer preoperative condition. Providing older patients with good breathing certainly improves their state of health and quality of life, which is so often compromised.
Reply,
We thank Casale and coworkers for their interesting comments on our article. 1 We particularly appreciated their suggestion to analyze the quality of life of elderly patients with chronic rhinosinusitis with nasal polyps (CRSwNP) after surgery, a topic not considered in our studies. Our group previously investigated the prognostic role of aging in CRSwNP in terms of the recurrence rate after surgery. In 2015, Brescia et al. 2 designed a prospective study with 179 consecutive patients to identify patients with CRSwNP who were at higher risk of recurrence after endoscopic sinus surgery by means of uni-and multivariate statistical models, and clinical, laboratory, and conventional pathologic parameters. In terms of disease recurrence, the discriminatory power of a panel of three variables (age Ͻ 65 years, serum basophil percentage, and histologic diagnosis of eosinophilictype CRSwNP) featured an area under the curve (receiver operating characteristic) of 0.703, and calibrating the model according to the Hosmer-Lemeshow scale indicated an acceptable discriminatory power. We concluded that higher-risk CRSwNP groups could be better identified by simultaneously considering more than one variable that characterize and differentiate CRSwNP cases.
CRSwNP is just one phenotype of chronic rhinosinusitis: clinical phenotypes definitely do not provide a full picture of all the underlying pathophysiologic cellular and molecular mechanisms 3 or prognostic factors. 4 Most of our group's investigations have focused on the fact that CRSwNP includes several endotypes. It may be possible to obtain information on the risk of disease progression or recurrence and on the best available treatment (which possibly involves innovative therapeutic targets) by endotyping CRSwNP based on pathologic mechanisms that differ functionally and pathologically, and that involve specific molecules or cells. 5 A histologic diagnosis of eosinophilic-type CRSwNP has generally been associated with a high recurrence rate after endoscopic sinus surgery. 6 From our viewpoint, the most intriguing preliminary outcome of this investigation on polyposis in the elderly was that, although the distribution of the eosinophilic and noneosinophilic types did not differ significantly between the two age groups considered, the pathologic diagnosis of eosinophilic-type CRSwNP was strongly associated with a higher recurrence rate in young adult patients (20-40 years old) but not in elderly patients. 1 Immune-mediated diseases may be influenced by aging, and, in the pathogenesis and development of CRSwNP, the role and biologic activity of eosinophils may be affected by aging.
In the field of CRSwNP, the greatest challenge for the future is to design further prospective investigations in a large series (which also includes biomarker assay in serum 7 and polyp tissue) to identify the different endotypes and establish rational, tailored diagnostic, therapeutic (medical and/or surgical), and follow-up modalities for patients with CRSwNP, even when they are elderly. Giuseppe Brescia, M.D. Umberto Barion, M.D. Gino Marioni, M.D.
